InfuSystem Holdings (INFU) Long-Term Deferred Tax (2011 - 2026)
InfuSystem Holdings' (INFU) quarterly Long-Term Deferred Tax came in at $4.2 million in Q1 2026, down 37.29% YoY from $6.7 million in Q1 2025, and down 8.79% on a QoQ basis from $4.6 million in Q4 2025.
InfuSystem Holdings (INFU) Long-Term Deferred Tax (2011 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 14 years of Long-Term Deferred Tax data on file, last reported at $4.2 million in Q1 2026.
- Quarterly Long-Term Deferred Tax fell 37.29% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 37.29% YoY) and the FY2025 annual result came in at $4.6 million, down 35.45% from the prior year.
- Long-Term Deferred Tax retreated to $4.2 million in Q1 2026, from $4.6 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $10.3 million in Q1 2022 to a low of $4.2 million in Q1 2026.
- A 5-year average of $8.1 million and a median of $9.1 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax climbed 1.28% — and 2025, when it tumbled 38.43%.
- Tracing INFU's Long-Term Deferred Tax over 5 years: stood at $9.6 million in 2022, then retreated by 5.3% to $9.1 million in 2023, then dropped by 21.14% to $7.2 million in 2024, then slumped by 35.45% to $4.6 million in 2025, then decreased by 8.79% to $4.2 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $4.2 million (Q1 2026), $4.6 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | InfuSystem Holdings | 244.47 Mn | 243.50 Mn | 21.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.58 Mn |
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 4.81 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 6.75 Mn |
| Dec 31, 2024 | 7.19 Mn |
| Sep 30, 2024 | 7.82 Mn |
| Jun 30, 2024 | 8.64 Mn |
| Mar 31, 2024 | 9.24 Mn |
| Dec 31, 2023 | 9.12 Mn |
| Sep 30, 2023 | 9.25 Mn |
| Jun 30, 2023 | 9.74 Mn |
| Mar 31, 2023 | 9.99 Mn |
| Dec 31, 2022 | 9.63 Mn |
| Sep 30, 2022 | 9.94 Mn |
| Jun 30, 2022 | 10.19 Mn |
| Mar 31, 2022 | 10.28 Mn |
| Dec 31, 2021 | 10.03 Mn |
| Sep 30, 2021 | 10.82 Mn |